Kiniksa Pharmaceuticals International, plc KNSA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's total assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported total assets of $825.28M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's total assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's total assets increased by 37.7% year-over-year, from $599.33M to $825.28M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's total assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's total assets has grown at a 16.9% compound annual growth rate (CAGR), from $349.46M to $763.63M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.